SAA1, serum amyloid A1, 6288

N. diseases: 188; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0162836
Disease: Hidradenitis Suppurativa
Hidradenitis Suppurativa
0.010 AlteredExpression disease BEFREE SAA and CRP levels and ESR were significantly associated with Hurley staging in patients with HS (P = 0.03, P = 0.003, P = 0.02). 31729595 2020
CUI: C0264964
Disease: Aneurysm of popliteal artery
Aneurysm of popliteal artery
0.010 Biomarker disease BEFREE A high prevalence of PA among subjects with screening detected AAA and SAA was found. 31757587 2020
CUI: C0003615
Disease: Appendicitis
Appendicitis
0.010 AlteredExpression disease BEFREE Plasma levels of IL-6, CRP, MCP-1, PCT, and SAA were significantly different in children with AA compared to those with NAAP (<i>p</i> < 0.001). 30918467 2019
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.010 AlteredExpression disease BEFREE Overexpression of SAA by hepatocytes also occurs in patients with pancreatic and colorectal cancers that have metastasized to the liver, and many patients with locally advanced and metastatic disease show increases in circulating SAA. 30842658 2019
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.010 Biomarker group BEFREE Despite the high burden of hypertension in SAA, strategies to improve awareness, diagnosis, and management are inadequate. 31451940 2019
CUI: C0031485
Disease: Phenylketonurias
Phenylketonurias
0.010 AlteredExpression group BEFREE The inflammatory markers C-reactive protein and serum amyloid A protein and the serum oxidative stress marker malondialdehyde were significantly higher in patients with PKU. 31492166 2019
CUI: C0032285
Disease: Pneumonia
Pneumonia
0.010 Biomarker disease BEFREE Regarding biomarkers, MR-proADM at 24 h (P = 0.04) and both suPAR and SAA at 48 h (P = 0.036 and P = 0.057) were associated with pneumonia. 31365180 2019
CUI: C0035344
Disease: Retinopathy of Prematurity
Retinopathy of Prematurity
0.010 GeneticVariation disease BEFREE Specifically, CpG methylation in the serum amyloid A SAA1 and SAA2, brain-derived neurotrophic factor (BDNF), myeloperoxidase (MPO), C-reactive protein (CRP), angiopoietin 1 (ANGPT1), and tumor necrosis factor receptor superfamily member 1B (TNFRSF1B) genes was associated with a lower risk of prethreshold ROP. 31266060 2019
CUI: C0041318
Disease: Tuberculosis, Meningeal
Tuberculosis, Meningeal
0.010 Biomarker disease BEFREE A modified version of the adult 7-marker biosignature in which transthyretin was replaced by NCAM1, diagnosed TBM in children with AUC of 0.80 (95% CI, 0.67-0.92), sensitivity of 73.9% (95% CI, 51.6-89.8%) and specificity of 66.7% (95% CI, 44.7-84.4%), with the other six proteins in the signature (CRP, IFN-γ, IP-10, CFH, Apo-A1, and SAA) only achieving and AUC of 0.75 (95% CI, 0.61-0.90) when used in combination. 31612118 2019
CUI: C0085693
Disease: Acute appendicitis NOS (disorder)
Acute appendicitis NOS (disorder)
0.010 AlteredExpression disease BEFREE Plasma levels of IL-6, CRP, MCP-1, PCT, and SAA were significantly different in children with AA compared to those with NAAP (<i>p</i> < 0.001). 30918467 2019
CUI: C0155877
Disease: Allergic asthma
Allergic asthma
0.010 Biomarker disease BEFREE Omalizumab is a recombinant monoclonal anti-IgE antibody approved in the US as add-on treatment in moderate-to-severe allergic asthma (in severe allergic asthma [SAA] in Europe). 30763137 2019
CUI: C0235031
Disease: Neurologic Symptoms
Neurologic Symptoms
0.010 AlteredExpression group BEFREE After introducing TCZ, her neurological symptoms and MRI findings gradually improved.SAA levels remained low. 31277158 2019
CUI: C0241868
Disease: acute aortic dissection
acute aortic dissection
0.010 Biomarker disease BEFREE Serum amyloid a protein as a potential biomarker in predicting acute onset and association with in-hospital death in acute aortic dissection. 31810459 2019
CUI: C0242379
Disease: Malignant neoplasm of lung
Malignant neoplasm of lung
0.010 Biomarker disease BEFREE Significantly higher blood concentrations of sPD-L1 and SAA1 were noted in lung cancer patients compared with a healthy control group. 31156344 2019
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.010 AlteredExpression phenotype BEFREE During early pancreatic tumorigenesis in mice, hepatocytes show activation of signal transducer and activator of transcription 3 (STAT3) signalling and increased production of serum amyloid A1 and A2 (referred to collectively as SAA). 30842658 2019
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.010 Biomarker disease BEFREE Significantly higher blood concentrations of sPD-L1 and SAA1 were noted in lung cancer patients compared with a healthy control group. 31156344 2019
CUI: C0701807
Disease: Acute anterior uveitis
Acute anterior uveitis
0.010 Biomarker disease BEFREE To investigate the association between serum amyloid A (SAA) protein and the clinical features of acute anterior uveitis (AAU), and to evaluate the disease activity and treatment effect in relation to SAA levels. 31844164 2019
CUI: C1306460
Disease: Primary malignant neoplasm of lung
Primary malignant neoplasm of lung
0.010 Biomarker disease BEFREE Significantly higher blood concentrations of sPD-L1 and SAA1 were noted in lung cancer patients compared with a healthy control group. 31156344 2019
CUI: C1701940
Disease: Pneumonia, Ventilator-Associated
Pneumonia, Ventilator-Associated
0.010 Biomarker disease BEFREE Diagnostic Efficacy of Serum Amyloid A Protein and Soluble Intercellular Adhesion Molecule 1 in Pediatric Ventilator-Associated Pneumonia. 28403662 2019
CUI: C3539878
Disease: Triple Negative Breast Neoplasms
Triple Negative Breast Neoplasms
0.010 Biomarker disease BEFREE Among the SAA receptors, <i>TLR1</i> and <i>TLR2</i> were highly expressed in TNBC. 30728901 2019
CUI: C3642346
Disease: Luminal B Breast Carcinoma
Luminal B Breast Carcinoma
0.010 Biomarker disease BEFREE Triple-negative breast cancer (TNBC) subtype highly expressed <i>SAA1/2</i> compared to HER2, luminal A (LA) and luminal B (LB) subtypes. 30728901 2019
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.010 Biomarker disease BEFREE We report the successful treatment of two patients with SAA, aged 15 and 24 months, with autologous cord blood combined with immunosuppression. 30407702 2019
CUI: C4722518
Disease: Triple-Negative Breast Carcinoma
Triple-Negative Breast Carcinoma
0.010 Biomarker disease BEFREE Among the SAA receptors, <i>TLR1</i> and <i>TLR2</i> were highly expressed in TNBC. 30728901 2019
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.010 AlteredExpression group BEFREE Clopidogrel prevented the early elevation of the plasma SAA protein level, decreased colitis severity, and delayed the formation of dysplastic lesions and adenocarcinoma. 29369476 2018
CUI: C0018817
Disease: Atrial Septal Defects
Atrial Septal Defects
0.010 Biomarker group BEFREE ASD (N = 36) assessed at age 10 years is associated with recurrent top quartile concentrations of inflammation-related proteins during the first post-natal month (e.g., SAA odds ratio (OR); 95% confidence interval (CI): 2.5; 1.2-5.3) and IL-6 (OR; 95% CI: 2.6; 1.03-6.4)). 29884819 2018